Cohen Children’s Medical Center ranks No. 1 on Long Island

Cohen Children’s Medical Center has been rated the No. 1 children’s hospital on Long Island – and recognized as second in New York State, sixth in the mid-Atlantic region – while earning top 40 national rankings for exceptional care in nine pediatric specialties, according to US News & World Report’s 2022-2023 Best Children’s Hospitals.

US News has ranked Cohen Children’s among the nation’s top pediatric hospitals for the 16th consecutive year. The Northwell Health children’s hospital, the largest provider of pediatric health services in the state, also serves as New York’s largest Level 1 pediatric trauma center and a primary destination for emergency care.

Cohen Children’s achieved top 30 national rankings in six disciplines: Neurology/neurosurgery as well as pediatric urology each ranked 20th, followed by orthopedics (22nd), Neonatology (24th), diabetes/endocrinology (27th) and nephrology (tied for 27th).

“Cohen Children’s Medical Center is consistently recognized for its excellent care in a number of specialties, but one heartening aspect that brings a smile to me is the warm reception each family receives during their stay,” said Michael Dowling, president and CEO of Northwell Health. “It’s extremely stressful and scary any time a child needs to be hospitalized. Our team delivers top-flight clinical care and they provide a reassuring and safe space for our young patients and their families to heal.”

Not only did Cohen Children’s rank No. 2 in New York State, but also sixth in the mid-Atlantic region, which includes Delaware, the District of Columbia, Maryland, New Jersey, New York, Pennsylvania, Virginia and West Virginia.

Below are Cohen Children’s pediatric specialties ranked by US News:

*        Denotes tie

“Our mission is so clear: The team members at Cohen Children’s take care of all infants, children and adolescents, no matter their means or level of illness or complexity,” said Charles Schleien, MD, MBA, senior vice president and chair of pediatric services at Northwell Health, and the Philip Lanzkowsky Chair and Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell. “The latest US News ranking makes clear that commitment to be good and do good.”

To view US News & World Report’s “Best Children’s Hospital’s” edition, go to:
https://health.usnews.com/best-hospitals/pediatric-rankings

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version